Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110áMBq (30ámCi) and 3700áMBq (100ámCi) post‐surgical 131I ablation …

MH Cherk, V Kalff, KSK Yap, M Bailey… - Clinical …, 2008 - Wiley Online Library
Objective To evaluate the relationships between thyroid remnant 131I uptake, radiation
thyroiditis and remnant ablation success rate between lower (1110áMBq) and higher …

Quantifying public radiation exposure related to lutetium-177 octreotate therapy for the development of a safe outpatient treatment protocol

C Olmstead, K Cruz, R Stodilka, P Zabel… - Nuclear Medicine …, 2015 - journals.lww.com
Objectives Radionuclide therapies, including treatment of neuroendocrine tumors with
lutetium-177 (Lu-177) octreotate, often involve hospital admission to minimize radiation …

Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment

AN Al-Haj, CS Lagarde, AM Lobriguito - Health physics, 2007 - journals.lww.com
Patients administered with a therapeutic dose of 131 I for thyroid cancer treatment are
potential sources of unacceptably high radiation exposure to other individuals, particularly …

Outpatient 131I-rituximab radioimmunotherapy for non-Hodgkin lymphoma: a study in safety

PJ Calais, JH Turner - Clinical Nuclear Medicine, 2012 - journals.lww.com
Purpose This study aimed to establish the safety of outpatient 131 I-rituximab
radioimmunotherapy by measuring the radiation exposure of hospital staff, carers, and …

Measurement of the dose to the family members taking care of thyroid cancer patients undergoing I-131 therapy in nuclear medicine using TLD-100

M Zehtabian, N Dehghan… - Radiation protection …, 2017 - academic.oup.com
The family members or friends of the patients undergoing treatment using radioiodine in
nuclear medicine are inevitably exposed to ionization radiation. The purpose of this study is …

Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations

RT Kloos - Thyroid, 2011 - liebertpub.com
F etuses whose mothers are treated with radioiodine after approximately 10–12 weeks of
pregnancy are at high risk of developing iatrogenic hypothyroidism (1). Other than this well …

[PDF][PDF] Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review

IA Al-Shakhrah - Clin J Oncol Nurs, 2008 - researchgate.net
Issa A. Al-Shakhrah, PhD, is an associate professor in medical physics in the Physics
Department at the University of Jordan in Amman. No financial relationships to disclose …

Доступность радиотерапии в современных условиях специализированного лечения онкологических больных

ОВ Моров, АВ Черниченко, РШ Хасанов - Онкология. Журнал им. ПА …, 2016 - elibrary.ru
Более 50% онкологических больных нуждаются в проведении радиотерапии. Однако в
мире объем ее применения онкологическим больным и доступность гораздо ниже …

[HTML][HTML] Measurement of radiation exposure to household contacts of patients with graves' disease treated with low dose radioactive iodine (131I) on outpatient basis

KH Salman, S Wagih, T Munshi, M Almalki… - The Egyptian Journal of …, 2018 - Elsevier
Abstract Background Patients with Graves' disease (GD) treated with 131 I represent
potential radiation hazard to others including household contacts. Radiation safety is …

New scrutiny of outpatient therapy with I-131

JA Harolds - Clinical nuclear medicine, 2011 - journals.lww.com
Recently, there has been a Congressional examination of the safety to the public when
outpatients are treated with I-131. The regulations regarding this procedure are being …